EU Lacks Reimbursement For AI-Based Medtech, Warn Manufacturers
Executive Summary
Medtech products based on artificial intelligence (AI) have the potential to transform the treatment paradigm in Europe, but manufacturers say reimbursement challenges are hindering product development.
You may also be interested in...
The Case For Novel Funding Models In Digitalization Of Devices
Digitalization can offer many benefits to European health care systems, but how does this look from a payer’s perspective? A health insurance expert has made the case for bundled reimbursement models based on shared risk and investment.
Germany’s Digital Health Fast-Track Scheme: What Manufacturers Need To Know
Understanding the German reimbursement system is crucial for any medtech firm eyeing the European market, and healthtech innovators in particular may benefit from its fast-track digital health app scheme. But how does the scheme work, and who can apply?
Why Measuring The Value Of AI In Medtech Is Complex, And Where Solutions Lie
The increased development of AI-enabled medtech means HTA bodies have a complex task on their hands. One set of researchers show how a multipronged approach is needed to assess the value of AI in medical imaging.